Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of PRX002 Administered By Intravenous Infusion in Patients With Parkinson's Disease

NCT02157714 is registered in ClinicalTrials.gov with Prothena Biosciences Limited as lead sponsor.

NCT NCT02157714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02157714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of PRX002 Administered By Intravenous Infusion in Patients With Parkinson's Disease
Lead sponsor
Prothena Biosciences Limited
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
Not reported
Enrollment
64 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease